VeriMom¿Es dihydroartemisinic acid seguro durante el embarazo?
No EU Cosmetic Regulation listing (Annex II/III), no harmonised CLP classification, no SCCS or CIR safety assessment located for DHAA, and no peer‑reviewed reproductive/developmental toxicity studies on DHAA were identified. PubChem/PubChemLite and the literature describe DHAA as an artemisinin precursor but do not report reproductive hazard data for DHAA itself; therefore default hazard and mechanism scores are 0. Moderate lipophilicity (predicted logP ≈3.7, MW 236) suggests low but measurable potential for dermal absorption from a cosmetic formulation (e=1). ([pubchemlite.lcsb.uni.lu](https://pubchemlite.lcsb.uni.lu/e/compound/11020893?utm_source=openai))
Related ingredients
Frequently asked questions
- ¿Es dihydroartemisinic acid seguro durante el embarazo?
- No EU Cosmetic Regulation listing (Annex II/III), no harmonised CLP classification, no SCCS or CIR safety assessment located for DHAA, and no peer‑reviewed reproductive/developmental toxicity studies on DHAA were identified. PubChem/PubChemLite and the literature describe DHAA as an artemisinin precursor but do not report reproductive hazard data for DHAA itself; therefore default hazard and mechanism scores are 0. Moderate lipophilicity (predicted logP ≈3.7, MW 236) suggests low but measurable potential for dermal absorption from a cosmetic formulation (e=1). ([pubchemlite.lcsb.uni.lu](https://pubchemlite.lcsb.uni.lu/e/compound/11020893?utm_source=openai))
- ¿Es dihydroartemisinic acid seguro durante la lactancia?
- Same evidence base as pregnancy: no regulatory or peer‑reviewed data indicating reproductive or lactation-specific hazard for DHAA. With no data of transfer into milk for DHAA, exposure scoring follows the adult topical route (low but measurable dermal absorption, e=1). No breastfeeding‑specific studies were found. ([pubchemlite.lcsb.uni.lu](https://pubchemlite.lcsb.uni.lu/e/compound/11020893?utm_source=openai))
- ¿Es dihydroartemisinic acid seguro para la piel del bebé?
- No infant‑specific toxicity or developmental dermatotoxicity data were found. Following your rules, because adult topical exposure is scored as measurable (e=1) and the compound is moderately lipophilic (logP ~3.7, MW 236) infant exposure is increased by +1 for immature barrier/higher SA:BW, giving e=2. Hazard and mechanism remain 0 in absence of reproductive/ED/teratogenic evidence. ([pubchemlite.lcsb.uni.lu](https://pubchemlite.lcsb.uni.lu/e/compound/11020893?utm_source=openai))
- ¿Cómo puntúa VeriMom a dihydroartemisinic acid?
- VeriMom puntúa dihydroartemisinic acid en 93/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a dihydroartemisinic acid en el embarazo?
- Consulta nuestra lista de alternativas seguras a dihydroartemisinic acid según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.